Lake Street Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $30
Craig-Hallum Maintains BioLife Solutions(BLFS.US) With Buy Rating, Announces Target Price $32
TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $31
BioLife Solutions Reports Strong Start to 2025
BioLife Solutions: Strong Financial Performance and Strategic Positioning Justify Buy Rating
Earnings Flash (BLFS) BioLife Solutions Posts Q1 Revenue $23.9M, Vs. FactSet Est of $22.2M
BioLife Solutions Updates Earnings Call Information
BioLife Solutions | 10-Q: Q1 2025 Earnings Report
BioLife Solutions Reports Q1 EPS (1c), Consensus (4c)
Express News | BioLife Solutions Q1 Adjusted Gross Margin 66%
Express News | BioLife Solutions Q1 Net Income USD -400 Thousand
Express News | BioLife Solutions Q1 Revenue USD 21.6 Million Vs. IBES Estimate USD 22.2 Million
Express News | BioLife Solutions Outlook FY Revenue USD 95.5-99 Million
BioLife Solutions 1Q Loss/Shr 1c >BLFS
Here Are the Major Earnings After the Close Today
Exploring BioLife Solns's Earnings Expectations
Earnings Preview: BLFS to Report Financial Results Post-market on May 08
BioLife Solutions to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025
Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?
BioLife Solutions Up Nearly 12%, on Pace for Largest Percent Increase Since October 2023 -- Data Talk